BridgeBio Pharma Inc
BBIO
Market Cap$4.28B
Close$
$-9.02
136.2% downside
Current Fair Value
136.2% downsideOvervalued by 136.2% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $4.28 Billion |
|---|---|
| Enterprise Value | $5.57 Billion |
| Dividend Yield | $0.0 (0.0%) |
| Earnings per Share | $-3.95 |
| Beta | 0.0 |
| Outstanding Shares | 175,831,536 |
| Avg 30 Day Volume | 1,607,764 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -6.65 |
|---|---|
| PEG | -29.95 |
| Price to Sales | - |
| Price to Book Ratio | -3.11 |
| Enterprise Value to Revenue | 598.71 |
| Enterprise Value to EBIT | -9.29 |
| Enterprise Value to Net Income | -9 |
| Total Debt to Enterprise | 0.31 |
| Debt to Equity | -1.28 |
Revenue Sources
No data
ESG Score
No data
About BridgeBio Pharma Inc
CEO: Neil Kumar